Physician profile
Michele A Rennard
NPI 1124374848
$806.85
in general payments reported to CMS, 2019-2025
6 companies · $120 in 2025
The $120 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.32 · 2020: $73.64 · 2021: $130 · 2022: $229 · 2023: $206 · 2024: $31.92 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $228.76 | 2022 | |
| Dentsply Sirona INC | $172.32 | 2021-2025 | Primescan Connect, Steri-Mate, Palodent Sectional Matrix System |
| Hu-Friedy Mfg. Co., LLC | $141.12 | 2020-2021 | |
| Neoss, INC. | $119.14 | 2023 | Neoss Implant System |
| Voco America INC. | $111.11 | 2019-2025 | Bifix Qm, Admira Fusion, Structur 2 |
| Orapharma, A Division of Bausch Health US, LLC | $34.40 | 2020-2024 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Rennard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.